People / Staff

Judith Usall I Rodié

Search publications

Publications

  • Huerta-Ramos ME, Ochoa S, Roca M, Miquel E and Usall J.

    The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report

    ARCHIVES OF WOMENS MENTAL HEALTH . 18(2): 259-261. Number of citations: 6

    [doi:10.1007/s00737-015-0500-9]

  • Brebion G, Stephan-Otto C, Huerta-Ramos ME, Ochoa S, Usall J, Abellán-Vega H, Roca M and Haro JM.

    Visual Encoding Impairment in Patients With Schizophrenia: Contribution of Reduced Working Memory Span, Decreased Processing Speed, and Affective Symptoms

    Neuropsychology . 29(1): 17-24. Number of citations: 15

    [doi:10.1037/neu0000104]

  • Ciocca G, Usall J, Dolz M, Limoncin E, Gravina GL, Carosa E, Sánchez B, Barajas A, Baños I, Huerta E, Farreny A, Franchi C, Group G and Ochoa S.

    Sexual dysfunctions in people with first-episode psychosis assessed according to a gender perspective

    RIVISTA DI PSICHIATRIA . 50(5): 239-244. Number of citations: 11

    [doi:10.1708/2040.22166]

  • Ochoa S, Haro JM, Huerta-Ramos ME, Cuevas-Esteban J, Stephan-Otto C, Usall J, Nieto L and Brebion G.

    Relation between jumping to conclusions and cognitive functioning in people with schizophrenia in contrast with healthy participants.

    SCHIZOPHRENIA RESEARCH . 159(1): 211-217. Number of citations: 29

    [doi:10.1016/j.schres.2014.07.026]

  • Brebion G, Stephan-Otto C, Huerta-Ramos ME, Usall J, Perez Del Olmo M, Contel M, Haro JM and Ochoa S.

    Decreased processing speed might account for working memory span deficit in schizophrenia, and might mediate the associations between working memory span and clinical symptoms.

    EUROPEAN PSYCHIATRY . 29(8): 473-478. Number of citations: 12

    [doi:10.1016/j.eurpsy.2014.02.009]

  • Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A and Huerta R.

    Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.

    JOURNAL OF CLINICAL PSYCHIATRY . 75(6): 608-615. Number of citations: 14

    [doi:10.4088/JCP.13m08551]

  • Huerta-Ramos ME, Iniesta R, Ochoa S, Cobo J, Miquel E, Roca M, Serrano-Blanco A, Teba F and Usall J.

    Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 24(2): 223-231. Number of citations: 64

    [doi:10.1016/j.euroneuro.2013.11.012]

  • Barajas A, Usall J, Baños I, Dolz M, Villalta-Gil V, Vilaplana M, Autonell J, Sánchez Fernández B, Cervilla JA, Foix-Sanjuan A, Obiols JE, Haro JM, GENIPE group and Ochoa S.

    Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis

    SCHIZOPHRENIA RESEARCH . 151(1-3): 252-258. Number of citations: 17

    [doi:10.1016/j.schres.2013.10.027]

  • Rubio E, Saenz Navarrete, G., Arranz B, Del Cacho, N., Cambra, R., Iniesta, R., Roca, M., Barneda, V. and Usall J.

    Reproductive side effects of antipsychotic-induced hyperprolactinemia; a cross-sectional study - preliminary results

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 23(2): 462-462.

    [doi:10.1016/S0924-977X(13)70731-4]

  • Farreny A, Aguado J, Ochoa S, Haro JM and Usall J.

    The role of negative symptoms in the context of cognitive remediation for schizophrenia.

    SCHIZOPHRENIA RESEARCH . 150(1): 58-63. Number of citations: 24

    [doi:10.1016/j.schres.2013.08.008]